Ali Behbahani
Director. Files against CRSP. Everything below is filed with the SEC within two business days of the trade. Filed as Behbahani Ali.
Every reported line
Purchases, sales, grants, option exercises and shares withheld for tax.
| Company | Action | Value |
|---|---|---|
| CRSPCRISPR Therapeutics AG2026-09-17 | Option exercise | $420K |
| CRSPCRISPR Therapeutics AG2026-09-17 | Sale | $780.9K |
| CRSPCRISPR Therapeutics AG2026-09-17 | Option exercisederivative | — |
| CRSPCRISPR Therapeutics AG2025-08-06 | J | — |
| CRSPCRISPR Therapeutics AG2025-08-06 | J | — |
Source: SEC Form 4 and Form 144 filings, via EDGAR. Form 144 carries no filer identifier, so those notices are matched to this page by name alone. Value is shares times the reported price, and is blank where the filing priced the transaction at zero — a grant costs its recipient nothing. Insiders sell for reasons that have nothing to do with the company, which is why a sale is not read as a signal on its own.
Follow Ali Behbahani by email
Ali Behbahani's new Form 4 trades, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.